Safety of Administering Live Vaccines during Pregnancy: A Systematic Review and Meta-Analysis of Pregnancy Outcomes
Live-attenuated vaccines (LAV) are currently contraindicated during pregnancy, given uncertain safety records for the mother−infant pair. LAV might, however, play an important role to protect them against serious emerging diseases, such as Ebola and Lassa fever. For this systematic review...
Main Authors: | Almudena Laris-González, Daniel Bernal-Serrano, Alexander Jarde, Beate Kampmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/1/124 |
Similar Items
-
Pregnancy outcome following M.MR vaccination
by: nahid Lorzadeh, et al.
Published: (2007-09-01) -
Influenza during pregnancy: vaccinal prevention of complications
by: I S Fedotova, et al.
Published: (2015-08-01) -
Refinement of a Live Attenuated <i>Salmonella enterica</i> Serovar Newport Vaccine with Improved Safety
by: Shamima Nasrin, et al.
Published: (2021-01-01) -
Live vaccination tactics: possible approaches for controlling visceral leishmaniasis
by: Noushin eSaljoughian, et al.
Published: (2014-03-01) -
Current Approaches to Develop a Live Vaccine against Leishmania majo
by: Farshid Yeganeh, et al.
Published: (2017-06-01)